BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27738517)

  • 1. Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction.
    Reinstadler SJ; Feistritzer HJ; Reindl M; Klug G; Mayr A; Mair J; Jaschke W; Metzler B
    Open Heart; 2016; 3(2):e000485. PubMed ID: 27738517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
    Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
    BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Mueller L; Koch C; Mayr A; Theurl M; Kirchmair R; Klug G; Metzler B
    Heart; 2017 Jun; 103(11):856-862. PubMed ID: 27979879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
    Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
    Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
    Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
    Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
    Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers enhance the long-term predictive ability of the KAMIR risk score in Chinese patients with ST-elevation myocardial infarction.
    Wang JJ; Fan Y; Zhu Y; Zhang JD; Zhang SM; Wan ZF; Su HL; Jiang N
    Chin Med J (Engl); 2019 Jan; 132(1):30-41. PubMed ID: 30628957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and left ventricular adverse remodelling after ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Tiller C; Mayr A; Klug G; Metzler B
    Int J Cardiol; 2016 Sep; 219():339-44. PubMed ID: 27348414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
    Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
    Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of versican mRNA transcript to predict cardiac remodelling after myocardial infarction.
    Chabior A; Gąsecka A; Marchel M; Gozdowska R; Makowska A; Maciak K; Góra M; Filipiak KJ; Burzyńska B; Opolski G
    Kardiol Pol; 2021; 79(7-8):833-840. PubMed ID: 34166520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction.
    Mohammad MA; Koul S; Smith JG; Noc M; Lang I; Holzer M; Clemmensen P; Jensen U; Engstrøm T; Arheden H; James S; Lindahl B; Metzler B; Erlinge D
    Am J Cardiol; 2018 Sep; 122(5):735-743. PubMed ID: 30049462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome.
    Kim H; Yang DH; Park Y; Han J; Lee H; Kang H; Park HS; Cho Y; Chae SC; Jun JE; Park WH
    Circ J; 2006 Nov; 70(11):1379-84. PubMed ID: 17062957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction.
    Mohammad MA; Koul S; Lønborg JT; Nepper-Christensen L; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Schoos MM; Göransson C; Engstrøm T; Erlinge D
    Am J Cardiol; 2020 Nov; 134():8-13. PubMed ID: 32933755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
    Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
    J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.